This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoellman, D. B.
Right arrow Articles by Appelbaum, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoellman, D. B.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2002, p. 220-224, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.220-224.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

In Vitro Antianaerobic Activity of Ertapenem (MK-0826) Compared to Seven Other Compounds

Dianne B. Hoellman,1 Linda M. Kelly,1 Kim Credito,1 Lauren Anthony,1 Lois M. Ednie,1 Michael R. Jacobs,2 and Peter C. Appelbaum1*

Department of Pathology (Clinical Microbiology), Hershey Medical Center, Hershey, Pennsylvania 17033,1 Department of Pathology (Clinical Microbiology), Case Western Reserve University, Cleveland, Ohio 441062

Received 28 March 2001/ Returned for modification 26 August 2001/ Accepted 25 September 2001

Ertapenem, imipenem, meropenem, ceftriaxone, piperacillin, piperacillin-tazobactam, clindamycin, and metronidazole were agar dilution MIC tested against 431 anaerobes. Imipenem, meropenem, and ertapenem were the most active ß-lactams (MICs at which 50% of the strains are inhibited [MIC50s], 0.125 to 0.25 µg/ml; MIC90s, 1.0 to 2.0 µg/ml). Time-kill studies revealed that ertapenem at two times the MIC was bactericidal for 9 of 10 strains after 48 h. The kinetics for other ß-lactams were similar to those of ertapenem.


* Corresponding author. Mailing address: Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail: pappelbaum{at}psu.edu.


Antimicrobial Agents and Chemotherapy, January 2002, p. 220-224, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.220-224.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Credito, K. L., Ednie, L. M., Appelbaum, P. C. (2008). Comparative Antianaerobic Activities of Doripenem Determined by MIC and Time-Kill Analysis. Antimicrob. Agents Chemother. 52: 365-373 [Abstract] [Full Text]  
  • Kononen, E., Bryk, A., Niemi, P., Kanervo-Nordstrom, A. (2007). Antimicrobial Susceptibilities of Peptostreptococcus anaerobius and the Newly Described Peptostreptococcus stomatis Isolated from Various Human Sources. Antimicrob. Agents Chemother. 51: 2205-2207 [Abstract] [Full Text]  
  • Jones, R. N., Huynh, H. K., Biedenbach, D. J., Fritsche, T. R., Sader, H. S. (2004). Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. J Antimicrob Chemother 54: 144-154 [Abstract] [Full Text]  
  • Cottagnoud, P., Pfister, M., Cottagnoud, M., Acosta, F., Tauber, M. G. (2003). Activities of Ertapenem, a New Long-Acting Carbapenem, against Penicillin-Sensitive or -Resistant Pneumococci in Experimental Meningitis. Antimicrob. Agents Chemother. 47: 1943-1947 [Abstract] [Full Text]  
  • Credito, K. L., Jacobs, M. R., Appelbaum, P. C. (2003). Time-Kill Studies of the Antianaerobe Activity of Garenoxacin Compared with Those of Nine Other Agents. Antimicrob. Agents Chemother. 47: 1399-1402 [Abstract] [Full Text]